Financial News Feed

Stronger Sell Today ALDX ranks #3394 as SELL CANDIDATE. Weaker Sell
Today ALDX ranks #3394 as SELL CANDIDATE.

ALDX stock Aldeyra Therapeutics

ALDX stock
Aldeyra Therapeutics

Both Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Avadel Pharmaceuticals plc (NASDAQ:AVDL) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regard...

Read more

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Dova Pharmaceuticals Inc. (NASDAQ:DOVA), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influen...

Read more

Following the trading signals on shares of Aldeyra Therapeu (ALDX), we note that the twenty one day Wilder Moving Average is currently under the 50 day Simple Moving Average. Traders may use this read...

Read more

As Biotechnology companies, Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) are our subject to contrast. And more specifically their analyst recommendations, pro...

Read more

As Biotechnology companies, Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Genocea Biosciences Inc. (NASDAQ:GNCA) are our subject to contrast. And more specifically their institutional ownership, earning...

Read more

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Arcturus Therapeutics Ltd. (NASDAQ:ARCT), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influen...

Read more

During Q4 2018 the big money sentiment decreased to 1.32. That's change of 1.36, from 2018Q3's 2.68. 15 investors sold all, 16 reduced holdings as Aldeyra...

Read more

This is a contrast between Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Voyager Therapeutics Inc. (NASDAQ:VYGR) based on their analyst recommendations, profitability, risk, dividends, earnings and valu...

Read more

We will be contrasting the differences between Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and XOMA Corporation (NASDAQ:XOMA) as far as institutional ownership,...

Read more

This is a contrast between Aldeyra Therapeutics Inc. (NASDAQ:ALDX) and Gritstone Oncology Inc. (NASDAQ:GRTS) based on their dividends, analyst recommendations,...

Read more

Equities research analysts predict that Aldeyra Therapeutics, Inc (NASDAQ:ALDX) will post earnings of ($0.41) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts...

Read more

Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) in the 4th quarter, according to its most recent filing with the SEC. The institu...

Read more

Taking a closer look at shares of Aldeyra Therapeu (ALDX), we can see that the beta research opinion is presently Buy. This signal uses a system combining volatility, momentum, and wave theory to help...

Read more

Since Intrexon Corporation (NASDAQ:XON) and Aldeyra Therapeutics Inc. (NASDAQ:ALDX) are part of the Biotechnology industry, they are influenced by compare. The...

Read more

We are comparing Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and Aldeyra Therapeutics Inc. (NASDAQ:ALDX) on their institutional ownership, analyst...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank